228 related articles for article (PubMed ID: 16632018)
1. Risk factors for acute renal insufficiency induced by diuretics in patients with congestive heart failure.
Sun WY; Reiser IW; Chou SY
Am J Kidney Dis; 2006 May; 47(5):798-808. PubMed ID: 16632018
[TBL] [Abstract][Full Text] [Related]
2. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, predictors and prognostic value of acute impairment in renal function during intensive unloading therapy in a community population hospitalized for decompensated heart failure.
Cioffi G; Tarantini L; Pulignano G; Del Sindaco D; De Feo S; Opasich C; Dilenarda A; Stefenelli C; Furlanello F
J Cardiovasc Med (Hagerstown); 2007 Jun; 8(6):419-27. PubMed ID: 17502758
[TBL] [Abstract][Full Text] [Related]
4. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
Cioffi G; Tarantini L; Stefenelli C; Azzetti G; Marco R; Carlucci S; Furlanello F
J Card Fail; 2006 Oct; 12(8):608-15. PubMed ID: 17045179
[TBL] [Abstract][Full Text] [Related]
5. [Long-term trends in drug prescription for hospitalized patients with congestive heart failure. Influence of type of dysfunction].
Grigorian Shamagian L; Varela Román A; Virgos Lamela A; Rigueiro Veloso P; García Acuña JM; González-Juanatey JR
Rev Esp Cardiol; 2005 Apr; 58(4):381-8. PubMed ID: 15847735
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety.
Ng TM; Hshieh S; Chan CY; Elkayam U
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):373-81. PubMed ID: 22610091
[TBL] [Abstract][Full Text] [Related]
7. Unloading therapy by intravenous diuretic in chronic heart failure: a double-edged weapon?
De Vecchis R; Ciccarelli A; Pucciarelli A
J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):571-4. PubMed ID: 20588135
[TBL] [Abstract][Full Text] [Related]
8. Effect of age on short and long-term mortality in patients admitted to hospital with congestive heart failure.
Gustafsson F; Torp-Pedersen C; Seibaek M; Burchardt H; Køber L;
Eur Heart J; 2004 Oct; 25(19):1711-7. PubMed ID: 15451149
[TBL] [Abstract][Full Text] [Related]
9. Serum and urinary magnesium during treatment of patients with chronic congestive heart failure.
Oladapo OO; Falase AO
Afr J Med Med Sci; 2000; 29(3-4):301-3. PubMed ID: 11714011
[TBL] [Abstract][Full Text] [Related]
10. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.
Majumdar SR; Kjellstrand CM; Tymchak WJ; Hervas-Malo M; Taylor DA; Teo KK
Am J Kidney Dis; 2009 Oct; 54(4):602-9. PubMed ID: 19535188
[TBL] [Abstract][Full Text] [Related]
11. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A
Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
[TBL] [Abstract][Full Text] [Related]
12. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y
Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782
[TBL] [Abstract][Full Text] [Related]
13. Congestive heart failure and ventricular arrhythmias in relation to serum magnesium.
Oladapo OO; Falase AO
Afr J Med Med Sci; 2000; 29(3-4):265-8. PubMed ID: 11714003
[TBL] [Abstract][Full Text] [Related]
14. Ultrafiltration for the treatment of diuretic-resistant, recurrent, acute decompensated heart failure: experience in a single center.
De Maria E; Pignatti F; Patrizi G; Benenati PM; Ricci S; Cappelli S
J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):599-604. PubMed ID: 20442667
[TBL] [Abstract][Full Text] [Related]
15. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
[TBL] [Abstract][Full Text] [Related]
16. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial.
Mahesh B; Yim B; Robson D; Pillai R; Ratnatunga C; Pigott D
Eur J Cardiothorac Surg; 2008 Mar; 33(3):370-6. PubMed ID: 18243724
[TBL] [Abstract][Full Text] [Related]
17. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Kurien S; Warfield KT; Wood CM; Miller WL
Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
[TBL] [Abstract][Full Text] [Related]
18. Predisposing factors for acute kidney injury in Hispanic patients treated with diuretics for decompensated heart failure.
Ricci F; Ramírez T; Marmorato R; Vega J; Pagán P; López JE; Soto-Salgado M; Cangiano JL
P R Health Sci J; 2013 Jun; 32(2):63-7. PubMed ID: 23781621
[TBL] [Abstract][Full Text] [Related]
19. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of renal dysfunction in patients with chronic heart failure: 12-month follow-up.
Roik M; Starczewska MH; Stawicki S; Solarska-Półchłopek A; Warszawik O; Oreziak A; Kochanowski J; Kosior D; Opolski G
Kardiol Pol; 2006 Jul; 64(7):704-11; discussion 712. PubMed ID: 16886127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
